abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Total Assets
$563.23M
Quarterly · Period ending: · USD
HQL Total Assets
Latest reported$563.23Mperiod ending
Latest reported$563.23Mperiod ending
HQL Quarterly Total Assets ($123.70M → $563.23M)
Quarterly total assets
High-resolution chart · PNG
HQL total assets history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Assets (USD) |
|---|---|
| 563,226,013 | |
| 515,382,000 | |
| 411,341,771 | |
| 460,583,216 | |
| 441,947,451 | |
| 402,600,476 | |
| 432,689,116 | |
| 414,725,362 | |
| 448,411,235 | |
| 534,185,320 | |
| 503,327,593 | |
| 484,165,561 | |
| 402,077,612 | |
| 386,981,946 | |
| 426,969,506 | |
| 478,469,725 | |
| 437,636,819 | |
| 468,332,000 | |
| 434,172,000 | |
| 417,632,000 | |
| 370,423,000 | |
| 467,854,000 | |
| 532,626,000 | |
| 444,841,000 | |
| 332,231,000 | |
| 302,819,000 | |
| 249,906,000 | |
| 227,484,821 | |
| 171,600,000 | |
| 214,200,000 | |
| 256,800,000 | |
| 260,950,000 | |
| 265,100,000 | |
| 273,050,000 | |
| 281,000,000 | |
| 295,050,000 | |
| 309,100,000 | |
| 289,950,000 | |
| 270,800,000 | |
| 250,550,000 | |
| 230,300,000 | |
| 211,700,000 | |
| 193,100,000 | |
| 193,050,000 | |
| 193,000,000 | |
| 175,450,000 | |
| 157,900,000 | |
| 186,900,000 | |
| 215,900,000 | |
| 101,400,000 | |
| 132,200,000 | |
| 127,950,000 | |
| 123,700,000 |